Polito Mary Zemyan, Thompson James W G, DeFina Philip A
Duquesne University, Pittsburgh, Pennsylvania, USA.
J Am Acad Nurse Pract. 2010 Sep;22(9):504-9. doi: 10.1111/j.1745-7599.2010.00540.x.
"The International Conference on Behavioral Health and Traumatic Brain Injury" held at St. Joseph's Regional Medical Center in Paterson, NJ., from October 12 to 15, 2008, included a presentation on the novel assessment and treatment approach to mild traumatic brain injury (mTBI) by Philip A. DeFina, PhD, of the International Brain Research Foundation (IBRF). Because of the urgent need to treat a large number of our troops who are diagnosed with mTBI and post-traumatic stress disorder (PTSD), the conference was held to create a report for Congress titled "Recommendations to Improve the Care of Wounded Warriors NOW. March 12, 2009." This article summarizes and adds greater detail to Dr. DeFina's presentation on the current standard and novel ways to approach assessment and treatment of mTBI and PTSD. Pilot data derived from collaborative studies through the IBRF have led to the development of clinical and research protocols utilizing currently accepted, valid, and reliable neuroimaging technologies combined in novel ways to develop "neuromarkers." These neuromarkers are being evaluated in the context of an "Integrity-Deficit Matrix" model to demonstrate their ability to improve diagnostic accuracy, guide treatment programs, and possibly predict outcomes for patients suffering from traumatic brain injury.
2008年10月12日至15日在新泽西州帕特森市圣约瑟夫地区医疗中心举行的“行为健康与创伤性脑损伤国际会议”,包含了国际脑研究基金会(IBRF)的菲利普·A·德菲纳博士关于轻度创伤性脑损伤(mTBI)新颖评估与治疗方法的演讲。由于迫切需要治疗大量被诊断为mTBI和创伤后应激障碍(PTSD)的军人,此次会议旨在为国会撰写一份题为《立即改善受伤战士护理的建议。2009年3月12日》的报告。本文总结了德菲纳博士关于mTBI和PTSD评估与治疗的当前标准及新颖方法的演讲,并补充了更多细节。通过IBRF合作研究得出的初步数据,促成了利用目前公认、有效且可靠的神经成像技术以新颖方式组合开发“神经标志物”的临床和研究方案的制定。这些神经标志物正在“完整性缺陷矩阵”模型的背景下进行评估,以证明其提高诊断准确性、指导治疗方案以及可能预测创伤性脑损伤患者预后的能力。